SaaS· individuals with ADHDPain 8.00/10WTP 6.0/10Market 8.0/10Validation 9.0Confidence 95%Sep 9, 2026

StimCrashTracker: Daily Dopamine & Crash Predictor for Stimulant Users

Long-term daily use of Vyvanse and other stimulants causes severe afternoon/evening emotional crashes, depression, and irritability that mimic chronic mental health struggles, leaving users without predictive insights or effective mitigation strategies.

analyticshealthindividuals with ADHDmobile-appproductivitysaassmall-businessworkflow
1
STAGE 01 · PROBLEM

Is the problem real?

CANONICAL PROBLEM

Long-term daily use of Vyvanse causes severe afternoon/evening emotional crashes, depression, and irritability that mimic chronic mental health struggles, leading users to mistakenly attribute side effects to external life factors.

FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.

PAIN TRIGGERS

Severe afternoon or evening crashes and emotional flattening caused by stimulant medication.
The difficult compromise between maintaining necessary daily productivity and suffering emotional side effects.
2
STAGE 02 · CUSTOMER

Who feels this pain?

TARGET USERS

individuals with ADHDLong Term Prescription Stimulant Users

Adults managing ADHD who experience debilitating afternoon/evening emotional crashes and depression as medication wears off.

Context

Manage ADHD symptoms effectively through medication without experiencing debilitating emotional crashes, depression, or loss of motivation when the drug wears off.
Attempting to fix chronic side effects via intensive lifestyle overhauls, supplements, and wellness routines.
Stopping medication entirely during extended breaks like summer vacation.

Current Workarounds

Attempting to fix chronic side effects via intensive lifestyle overhauls and supplements
Stopping medication entirely during extended breaks like vacations
Experimenting unsafely with alternate dosages or splitting capsules
3
STAGE 03 · MARKET

Where's the gap?

EXISTING SOLUTION GAPS

Standard psychiatric follow-ups often fail to proactively address or anticipate gradual daily crash side effects over multi-year periods.
Lifestyle and wellness interventions (diet, exercise, meditation) fail to resolve medication-induced neurochemical drops.

OPPORTUNITY & VALUE

Why Now

Strong repeated complaints across multiple users experiencing severe afternoon/evening emotional crashes and depression from daily stimulant use.

Value Proposition

Purpose-built specifically for stimulant wear-off management rather than general mental health tracking or generic habit building.

Product Direction

A lightweight tracking and predictive timing tool that correlates daily habits, dosage timing, and crash severity to provide actionable pre-crash interventions and smooth out transitions.

4
STAGE 04 · BUSINESS

How does it make money?

MONETIZATION

$9/moIndividual monthly subscription

Model

SaaS subscription
WILLINGNESS TO PAY

Users spend significant money on supplements and lifestyle fixes trying to solve crashes; $9/mo is a minor fraction of that spend for targeted relief and avoiding lost evenings.

5
STAGE 05 · EXECUTION

How do you ship it?

MVP PLAN

Predict your stimulant crash before it ruins your evening.

A lightweight tracking and predictive timing tool that correlates daily habits, dosage timing, and crash severity to provide actionable pre-crash interventions and smooth out transitions.

Core Features

Daily check-in for mood, energy, and crash timing
Automated timing recommendations for nutritional or lifestyle buffers

Weekly Roadmap

1
W1-W2
Core logging interface for medication timing and crash mood tracking.
  • Build minimalist daily check-in flow
  • Set up secure local database schema
  • Implement simple trend visualization graph
2
W3-W4
Automated alert engine and correlation algorithm functional.
  • Build algorithm to predict crash windows based on intake time
  • Implement push notification reminders before peak crash hours
  • Add supplement and lifestyle logging tags
3
W5
Payment integration and private beta testing with 10 users.
  • Integrate Stripe for monthly subscription
  • Onboard 10 ADHD community testers from Reddit
  • Refine notification timing based on feedback
4
W6
Public launch in target communities.
  • Publish launch post on r/ADHD
  • Set up landing page with clear privacy guarantees
  • Monitor initial user acquisition and crash prediction accuracy
Launch Strategy

Target Reddit communities (r/ADHD, r/vyvanse) where users openly discuss afternoon crashes and emotional toll.

RISKS & ASSUMPTIONS

Top Risks

Medical advice liability

Users might misconstrue app timing recommendations as medical advice for prescription dosages.

SEV 4
Low engagement during low-energy crashes

Users experiencing severe depressive crashes have zero motivation to open an app and log data.

SEV 4
Data privacy concerns

Handling sensitive medication and psychological health data requires strict privacy compliance.

SEV 3
6
STAGE 06 · DECISION

Should you build it?

NEED A CLEARER CALL?

Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.

Generate an investment memo

What this score means

This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 2 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.

Why this matters for SaaS founders

It sits at the intersection of "analytics", "health", "individuals with ADHD", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.

Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works

Frequently asked questions

Is "StimCrashTracker: Daily Dopamine & Crash Predictor for Stimulant Users" a real validated startup idea or just an AI-generated suggestion?

MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.

How recent is the underlying data for analytics?

MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.

What's the difference between "overall score" and "validation score"?

Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.